ILDSTAD SUZANNE (Chief Scientific Officer) sold 1.2% of their position (33.39K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $84.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/7/2023ACC: 0001209191-23-035217
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-33.39K
Net shares
Net seller
$84.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
33.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.84K
Price / share
$2.52
Trade value
$19.75K
% of position
0.3%
6/5/2023
2.79M→2.78M
Common Stock
Direct
Shares
−25.55K
Price / share
$2.53
Trade value
$64.60K
% of position
0.9%
6/6/2023
2.78M→2.76M
Total
Net shares
−33.39K
Net value
-$84.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2023 | S · Sale | −7.84K | $2.52 | $19.75K | 0.3% | 2.79M | 2.78M |
| Common Stock Direct | 6/6/2023 | S · Sale | −25.55K | $2.53 | $64.60K | 0.9% | 2.78M | 2.76M |
| Total | −33.39K | -$84.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported